Hikma Pharmaceuticals PLC
HKMPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $359,000 | $190,000 | $188,000 | $421,000 |
| Dep. & Amort. | $197,000 | $190,000 | $182,000 | $169,000 |
| Deferred Tax | $0 | $0 | $76,000 | $99,000 |
| Stock-Based Comp. | $27,000 | $25,000 | $22,000 | $29,000 |
| Change in WC | -$213,000 | -$8,000 | -$98,000 | -$128,000 |
| Other Non-Cash | $194,000 | $211,000 | $160,000 | $48,000 |
| Operating Cash Flow | $564,000 | $608,000 | $530,000 | $638,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$165,000 | -$169,000 | -$138,000 | -$145,000 |
| Net Acquisitions | -$150,000 | -$105,000 | -$380,000 | -$17,000 |
| Inv. Purchases | $0 | -$27,000 | -$15,000 | -$3,000 |
| Inv. Sales/Matur. | $0 | $1,000 | $395,000 | $6,000 |
| Other Inv. Act. | -$66,000 | -$33,000 | -$469,000 | -$79,000 |
| Investing Cash Flow | -$381,000 | -$333,000 | -$607,000 | -$238,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $124,000 | -$73,000 | $430,000 | -$83,000 |
| Stock Issued | -$38,000 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$300,000 | $0 |
| Dividends Paid | -$175,000 | -$137,000 | -$125,000 | -$120,000 |
| Other Fin. Act. | -$99,794 | -$127,000 | -$63,000 | -$84,000 |
| Financing Cash Flow | -$188,000 | -$337,000 | -$58,000 | -$287,000 |
| Forex Effect | -$12,000 | -$3,000 | -$21,000 | -$10,000 |
| Net Chg. in Cash | -$17,000 | -$65,000 | -$156,000 | $103,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $205,000 | $270,000 | $426,000 | $323,000 |
| End Cash | $188,000 | $205,000 | $270,000 | $426,000 |
| Free Cash Flow | $399,000 | $439,000 | $392,000 | $493,000 |